European Bronchitis Treatment Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
European bronchitis treatment market is projected to grow at a significant CAGR of around 3.5%
during the forecast period (2020-2026). The market for bronchitis treatment in
European region is expected to project a modest growth during the forecast
period, backed by the rising prevalence of lung related diseases in the Western
European nations, such as UK. As per the European Lung Foundation, around 16.5
million cases of acute bronchitis are registered every year in the region.
Moreover, the bronchiolitis is one of the most common causes of hospital
admissions in the first 12 months of children, leading to the growth of the
bronchitis treatment market among children in the country.
To Request a Sample of our Report on European Bronchitis
Treatment Market: https://www.omrglobal.com/request-sample/europe-bronchitis-treatment-market
The well-developed infrastructure of Europe has attracted the
attention of global market players to expand their presence in the region,
which in turn, is offering growth to the market. Moreover, European Lung
Foundation is engaged in several research projects, funded by the European
Union (EU). For instance, FRESH AIR is an EU Horizon 2020 project that has a
goal of improving the health of individuals that are at risk or are currently
dealing with chronic lung conditions in European countries that have limited
resources of treatment, such as Vietnam, Uganda, Greece, and Kyrgyz Republic.
These projects are expected to offer growth to the bronchitis treatment market
in the region during the forecast period.
(Get 15% Discount on Buying this Report)
A full
Report of European Bronchitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/europe-bronchitis-treatment-market
European Bronchitis Treatment Market – Segmentation
By Technology
·
Medication
·
Antibiotics
·
Anti-inflammatory drugs
·
Bronchodilators
·
Others (Mucolytics)
·
Oxygen Therapy
European Bronchitis Treatment Market – Segmentation by
Geography
·
UK
·
Germany
·
France
·
Italy
·
Spain
·
Rest of Europe
Company Profiles
·
Abbott Laboratories
·
Bayer AG
·
Boehringer Ingelheim International GmbH
·
Cipla Ltd.
·
GlaxoSmithKline PLC
·
Lupin Pharmaceuticals, Inc.
·
Merck & Co., Inc.
·
Novartis AG
·
Pfizer Inc.
·
Sanofi SA
·
Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-bronchitis-treatment-market
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment